Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer

NCT ID: NCT02704312

Last Updated: 2022-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2022-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compare dosimeters in both positions (prone and decubitus) for each patient

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radiotherapy techniques

Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose)

Group Type EXPERIMENTAL

Radiotherapy by Prone and decubitus

Intervention Type RADIATION

Dosimetric comparison of doses in target volumes and organs at risk

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Radiotherapy by Prone and decubitus

Dosimetric comparison of doses in target volumes and organs at risk

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with primary breast cancer and in whom conservative post- surgery radiation therapy for breast cancer is prescribed.
* Patients aged over 18 years
* Patients with indication for conservative surgery.
* Resection should be in healthy margin.
* Women of childbearing potential must satisfy a negative pregnancy test at the screening visit and use effective contraception as determined by the physician of the patient throughout the study.

Exclusion Criteria

* Minor Patient
* Patients whose tumor resection is incomplete
* Patients with an indication of mastectomy
* Patients with a history of radiation therapy of the chest
* Pregnant women, lactating, or of childbearing age without effective contraception.
* Patients who had more than 4 scanners in one year. ( Scanner cervical , thoracic, or abdominal
* Patients with an incompatible condition with monitoring protocol (psychiatric disorder, uncontrolled disease).
* Patient unable to respond to a questionnaire
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Center of Martinique

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent VINH HUNG, MD

Role: PRINCIPAL_INVESTIGATOR

CHU de Martinique

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Martinique

Fort-de-France, , Martinique

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Martinique

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15/ B/ 25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.